Oncomedics Overview

  • Founded
  • 2006
Founded
  • Status
  • Private
  • Employees
  • 8
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $605K
Latest Deal Amount
  • Investors
  • 5

Oncomedics General Information

Description

Provider of biotechnology research services intended to make targeted chemotherapy for each patient in order to increase its effectiveness. The company's services predicts the effect of a molecule on a patient's tumor according to the principle of the antibiogram as well as permit oncologists to personalize the treatment by avoiding drugs that are inactive on the cells and by preferring those with strong anti-cancer activity, enabling clinicians and doctors to receive tested drugs and therapies for the immediate treatment of patients suffering from cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Diagnostic Equipment
Primary Office
  • ESTER Technopôle
  • 1 avenue d'Ester
  • 87069 Limoges
  • France
+33 05 00 00 00 00

Oncomedics Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Oncomedics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 15-May-2019 $605K 00.00 00.000 Completed Generating Revenue
4. Later Stage VC 20-Dec-2017 00000 00000 00.000 Completed Generating Revenue
3. Later Stage VC 01-Jul-2016 Completed Generating Revenue
2. Secondary Transaction - Private Completed Startup
1. Early Stage VC Completed Startup
To view Oncomedics’s complete valuation and funding history, request access »

Oncomedics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000 0000.0 0000.0 00 0000.0 000
Ordinary 0,000 0000.00 0000.00 00 0000.00 0.000
To view Oncomedics’s complete cap table history, request access »

Oncomedics Executive Team (3)

Name Title Board Seat Contact Info
Christophe Lautrette Ph.D Chief Executive Officer, Chairman, Co-Founder & President
Stéphanie Giraud Ph.D Co-Founder, Director of Research, Chief Scientific Officer & Scientific Director
Grégoire Prévost Ph.D Advisor
To view Oncomedics’s complete executive team members history, request access »

Oncomedics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oncomedics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Limousin Business Angels Angel Group Minority 000 0000 000000 0
Dynalim Growth/Expansion Minority 000 0000 000000 0
Femmes Business Angels Angel Group Minority 000 0000 000000 0
Limousin Participations Growth/Expansion Minority 000 0000 000000 0
Sofimac Investment Managers Venture Capital Minority 000 0000 000000 0
To view Oncomedics’s complete investors history, request access »